June 23, 2017 11:58 AM ET

Biotechnology

Company Overview of Veracyte, Inc.

Key Executives for Veracyte, Inc.

NameBoard RelationshipsTitleAge
Bonnie H. Anderson 20 RelationshipsCo-Founder, Chairman and Chief Executive Officer58
Christopher M. Hall No RelationshipsPresident and Chief Operating Officer47
Keith S. Kennedy CFA, CPANo RelationshipsChief Financial Officer46
Neil M. Barth M.D., FACPNo RelationshipsChief Medical Officer--
Julie A. Brooks J.D.No RelationshipsExecutive Vice President, General Counsel and Secretary70
View More Key Executives

Veracyte, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Bonnie H. Anderson 20 RelationshipsVeracyte, Inc.58
Evan Jones M.B.A. 43 RelationshipsOpGen, Inc.59
Karin Eastham CPA, MBA 61 RelationshipsIllumina, Inc.67
Robert S. Epstein M.D., M.S. 38 RelationshipsMedco Research Institute, L.L.C.61
Tina S. Nova Bennett Ph.D. 65 RelationshipsIllumina, Inc.62
View All Board Members

Veracyte, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CPA, MBAKarin Eastham61 Relationships3 Executives
Compensation Committee M.B.A.Evan Jones43 Relationships2 Executives
Nominating Committee M.D., M.S.Robert S. Epstein38 Relationships2 Executives
Corporate Governance Committee M.D., M.S.Robert S. Epstein38 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$500.0K
500.0K
390.2K
Bonus
Not meaningful
Total Short Term Compensation$500.0K
500.0K
486.3K
Total Value of Options
18.2M
Compensation as of Fiscal Year
Veracyte, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

VBL Therapeutics Appoints Corinne Epperly as U.S. Chief Operating Officer
June 22, 2017 8:34 PM ET
Biohaven Pharmaceutical Holding Company Ltd. and Biohaven Pharmaceuticals, Inc. Announce Executive Appointments
June 22, 2017 7:00 AM ET
ValiRx plc Announces Executive Changes
June 22, 2017 6:00 AM ET
Affimed N.V. Appoints Wolfgang Fischer as New Managing Director
June 21, 2017 8:31 PM ET
Five Prime Therapeutics, Inc. Announces Executive Changes
June 21, 2017 8:11 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Veracyte, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.